Genzyme - GENZ | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Genzyme - GENZ

An SI Board Since January 2003

Posts	SubjectMarks	Bans	Symbol
10	1	0	GENZ

Emcee: Ron Mgrublian	Type: Unmoderated

Introduction Market Data Compact

Genzyme General Division is a division of Genzyme Corporation, a biotechnology and human healthcare company that develops products and provides services for unmet medical needs. Genzyme General develops and markets therapeutic products and diagnostic products and services with an emphasis on genetic disorders and other chronic debilitating diseases with well-defined patient populations. The Company is organized into two segments, Therapeutics, which focuses on developing and marketing products for genetic diseases and other chronic debilitatingdiseases, including a family of diseases known as lysosomal storage disorders, and specialty therapeutics, and Diagnostic Products, which develops, markets and distributes in vitro diagnostic products. The Company also operates a wholly owned subsidiary, GelTex Pharmaceuticals, Inc., which Genzyme General acquired in December 2000.

biz.yahoo.com

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
10	Genzyme's manufacturing issues may take 4 years to fix. Yikes! >>San	tuck	-	8/16/2010
9	Genzyme says FDA OKs stem cell transplant drug Mon Dec 15, 2008 5:52pm EST NEW	tnsaf	-	12/15/2008
8	Icahn Cashes Out of Genzyme Posted by Jacob Goldstein February 15, 2008, 9:01	Doc Bones	-	2/19/2008
7	Icahn just filed a new position. Nice move in AH.	Keith Feral	-	11/14/2007
6	[graphic]	tom pope	-	7/8/2007
5	ML brushes the failure aside. If they're right, it is an interesting buy: &	tom pope	-	7/8/2007
4	GENZ does not meet endpoint for c. dificle drug..no position but follow via VPHM	zeta1961	-	7/7/2007
3	Genzyme's hylastan misses goal in arthritis trial Thu Jul 5, 2007 9:14AM EDT	idos	-	7/5/2007
2	9:46AM Bioenvision: GENZ extends tender offer to acquire Bioenvision (BIVN) 5.80	BenThair	-	7/2/2007
1	FDA panel positive on Genzyme drug Panel's move could open door for final FD	Ron Mgrublian	-	1/13/2003

Go to reply# or date (mm/dd/yy):